Evommune (EVMN) Amortizatization of Intangibles (2024 - 2026)
Evommune's (EVMN) quarterly Amortizatization of Intangibles came in at $792000.0 in Q1 2026, up 86.35% year-on-year from $425000.0 in Q1 2025, and up 35.38% on a QoQ basis from $585000.0 in Q4 2025.
Evommune (EVMN) Amortizatization of Intangibles (2024 - 2026) Analysis & Trends
Evommune (EVMN) has 3 years of Amortizatization of Intangibles data on file, last reported at $792000.0 in Q1 2026.
- On a quarterly basis, Amortizatization of Intangibles rose 86.35% year-over-year to $792000.0 in Q1 2026; TTM through Mar 2026 was $2.2 million, a N/A change from a year earlier, with the FY2025 full-year figure at $1.8 million, down 2.8% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $792000.0, up from $585000.0 in the prior quarter.
- Over the last five years, Amortizatization of Intangibles for EVMN reached as high as $792000.0 in Q1 2026 and fell as low as $425000.0 in Q1 2025.
- Historically, Amortizatization of Intangibles has averaged $562000.0 across 3 years, with a median of $515500.0 in 2024.
- Across the five-year window, Amortizatization of Intangibles soared 31.17% in 2025 and jumped 86.35% in 2026, its largest moves.
- Year by year, Amortizatization of Intangibles stood at $446000.0 in 2024, then jumped by 31.17% to $585000.0 in 2025, then jumped by 35.38% to $792000.0 in 2026.
- Per Business Quant data, the three most recent Amortizatization of Intangibles figures were $792000.0 in Q1 2026, $585000.0 in Q4 2025, and $425000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Evommune | 386.53 Mn | 175.07 Mn | - | 792,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 792,000.00 |
| Mar 31, 2026 | 792,000.00 |
| Dec 31, 2025 | 585,000.00 |
| Dec 31, 2025 | 585,000.00 |
| Mar 31, 2025 | 425,000.00 |
| Mar 31, 2025 | 425,000.00 |
| Dec 31, 2024 | 446,000.00 |
| Dec 31, 2024 | 446,000.00 |